Učitavanje...
Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma
Despite a range of efficacious therapies for asthma, including inhaled corticosteroids (ICS) and long-acting β(2)-agonists (LABA), a significant proportion of patients have poor asthma control and retain a risk of future worsening of their symptoms. Long-acting muscarinic antagonist (LAMA) bronchodi...
Spremljeno u:
| Izdano u: | Allergy Asthma Immunol Res |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5500692/ https://ncbi.nlm.nih.gov/pubmed/28677351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4168/aair.2017.9.5.386 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|